Equities

Aeon Biopharma Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Aeon Biopharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.00
  • Today's Change0.051 / 5.41%
  • Shares traded61.57k
  • 1 Year change-89.32%
  • Beta0.7366
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Aeon Biopharma Inc (AEON:ASQ) closed at 1.00, 166.67% above the 52 week low of 0.375 set on Apr 11, 2025.
52-week range
Today
0.375Apr 11 20259.71Feb 21 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.9392
High1.03
Low0.9392
Bid0.9403
Offer1.02
Previous close0.9487
Average volume90.72k
Shares outstanding24.02m
Free float10.43m
P/E (TTM)0.2054
Market cap24.02m USD
EPS (TTM)4.87
USD
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼

Events & Activity

  • AEON:ASQ price moved over -5.77% to 0.98
  • AEON:ASQ trading volume exceeds daily average by +18.94%
  • AEON:ASQ price falls below 50-day moving average to 1.04 at 14:30 GMT
  • AEON:ASQ price falls below 50-day moving average to 1.02 at 14:30 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.